Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis

New meta‐analyses are presented that provide further evidence supporting the effectiveness of oral prolonged‐release mesalazine compared to other oral mesalazines as induction therapy in patients with moderately active ulcerative colitis.[Image: see text]

Detalles Bibliográficos
Autores principales: Paridaens, Kristine, Fullarton, John R, Travis, Simon P L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366489/
https://www.ncbi.nlm.nih.gov/pubmed/37496812
http://dx.doi.org/10.1002/jgh3.12935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366489/
https://www.ncbi.nlm.nih.gov/pubmed/37496812
http://dx.doi.org/10.1002/jgh3.12935

Ejemplares similares